Clinical Trials Directory

Trials / Completed

CompletedNCT00627302

Efficacy of PEG-400 and Systane Artificial Tears (Alcon) on Quality of Vision

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Bp Consulting, Inc · Network
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

To evaluate the effect of PEG-400 and Systane on quality of vision after LASIK.

Conditions

Interventions

TypeNameDescription
DRUGPEG-400Day of Surgery: Starting 2 hours after surgery Instill one drop in randomized eye every two hours. Day 1-Week 1: Instill one drop in randomized eye four times daily
DRUGSystaneDay of Surgery: Starting 2 hours after surgery Instill one drop in randomized eye every two hours. Day 1-Week 1: Instill one drop in randomized eye four times daily

Timeline

Start date
2008-02-01
Primary completion
2008-11-01
Completion
2008-11-01
First posted
2008-03-03
Last updated
2008-11-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00627302. Inclusion in this directory is not an endorsement.